CPT 87276: Influenza A Immunofluorescent Antigen Detection
CPT code 87276 denotes an immunofluorescent antibody staining assay with fluorescence microscopy to detect influenza A virus antigens. This laboratory-based diagnostic procedure is clinically important for timely identification of influenza A, informing infection control and clinical decision-making across inpatient and outpatient settings. Nationally, accurate coding of such tests influences surveillance, reporting, and reimbursement for laboratory services.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for antigen-based influenza testing, payer coverage patterns, and where CPT 87276 fits among laboratory diagnostic services. The publication outlines typical sites of service and operational considerations for laboratories offering immunofluorescent antigen detection.
The report provides benchmarks and policy context relevant to CPT code 87276, including common billing practices and coding considerations for labs and billing teams. Data not available in the input will be noted where applicable.
Customize your policy alerts
Sign up for cpt 87276 policy alerts
Get alerted when payer policies referencing 87276 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 87276 describes a laboratory test in which a clinical laboratory analyst detects influenza A virus antigens using immunofluorescent antibody staining and fluorescence microscopy. This assay is a type of infectious disease antigen detection performed by trained laboratory personnel to identify viral proteins from respiratory specimens.
-
Service type: Laboratory diagnostic test (immunofluorescent antigen detection)
-
Typical site of service: Hospital clinical laboratory, specialized reference laboratory, or outpatient laboratory facility where microscopy and fluorescence immunostaining are performed.